Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
6.91
-0.08 (-1.14%)
At close: Feb 13, 2026, 4:00 PM EST
7.00
+0.09 (1.30%)
After-hours: Feb 13, 2026, 5:29 PM EST
Aligos Therapeutics Employees
Aligos Therapeutics had 70 employees as of December 31, 2024. The number of employees increased by 4 or 6.06% compared to the previous year.
Employees
70
Change
4
Growth
6.06%
Revenue / Employee
$37,800
Profits / Employee
-$1,235,171
Market Cap
42.52M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 70 | 4 | 6.06% |
| Sep 30, 2024 | 68 | 0 | - |
| Jun 30, 2024 | 68 | 0 | - |
| Mar 31, 2024 | 67 | -2 | -2.90% |
| Dec 31, 2023 | 66 | -17 | -20.48% |
| Sep 30, 2023 | 68 | -21 | -23.60% |
| Jun 30, 2023 | 68 | -21 | -23.60% |
| Mar 31, 2023 | 69 | -26 | -27.37% |
| Dec 31, 2022 | 83 | -10 | -10.75% |
| Sep 30, 2022 | 89 | 3 | 3.49% |
| Jun 30, 2022 | 89 | 3 | 3.49% |
| Mar 31, 2022 | 95 | 26 | 37.68% |
| Dec 31, 2021 | 93 | 19 | 25.68% |
| Sep 30, 2021 | 86 | 13 | 17.81% |
| Jun 30, 2021 | 86 | 19 | 28.36% |
| Mar 31, 2021 | 69 | 8 | 13.11% |
| Dec 31, 2020 | 74 | 13 | 21.31% |
| Sep 30, 2020 | 73 | 12 | 19.67% |
| Jun 30, 2020 | 67 | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Xilio Therapeutics | 64 |
| NextCure | 43 |
| LeonaBio | 26 |
| Lisata Therapeutics | 26 |
| ABVC BioPharma | 19 |
| CervoMed | 15 |
| Apollomics | 13 |
| Cingulate | 13 |
ALGS News
- 16 days ago - Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 25 days ago - Aligos Therapeutics Provides Phase 2 B-SUPREME Study Progress Updates - GlobeNewsWire
- 2 months ago - Aligos Therapeutics Presents Positive Data at HEP-DART 2025 - GlobeNewsWire
- 3 months ago - Aligos Therapeutics, Inc. (ALGS) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 3 months ago - Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2025 - GlobeNewsWire
- 3 months ago - Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - Aligos Therapeutics to Present at Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Aligos Therapeutics to Announce 3rd Quarter 2025 Financial Results on November 6, 2025 - GlobeNewsWire